The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis
Abstract
Objective: There is substantial evidence supporting the role of interferon (IFN)‐γ–producing T helper (T H ) 1 and interleukin (IL)‐17–expressing T H 17 lymphocytes in multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE). However, to date little is known about the potential cooperative interplay between these 2 cytokines. In the current study, we sought to evaluate the frequency of IFN‐γ–expressing T H 17 lymphocytes in MS and EAE, and study their recruitment into the central nervous system (CNS). Methods: Human T H 17 lymphocytes were expanded in vitro from the blood of healthy controls and relapsing MS patients using IL‐23. Immune cell migration to the CNS was assessed in vitro with primary cultures of human blood–brain barrier (BBB)‐derived endothelial cells, and in vivo in EAE mice. Results: We demonstrate that in response to IL‐23, human memory lymphocytes expand into a T H 17 phenotype, with a subpopulation of cells simultaneously expressing IFN‐γ and IL‐17. We note that lymphocytes obtained from the blood of relapsing MS patients have an increased propensity to expand into IFN‐γ–producing T H 17 cells and identify numerous T lymphocytes coexpressing IL‐17 and IFN‐γ in brain tissue of MS patients. We also find lymphocytes expressing both the T H 1‐ and the T H 17‐associated transcription factors RORγt and T‐bet, in situ and in vitro. We further provide in vitro and in vivo evidence that IFN‐γ + T H 17 lymphocytes preferentially cross the human BBB and accumulate in the CNS of mice during the effector phase of EAE. Interpretation: Our data underscore the involvement of IFN‐γ + T H 17 lymphocytes in the pathology of MS and EAE and their preferential recruitment into the CNS during inflammatory events. Ann Neurol 2009;66:390–402
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, some studies show a protective function for IL-17A in colitis [128, 129], possibly due to the role of IL-17A in promoting intestinal epithelial barrier integrity [130].”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [128]
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Morgan, R. A., Chinnasamy, N., Abate‐Daga, D., Gros, A., Robbins, P. F., Zheng, Z., Dudley, M. E., Feldman, S. A., Yang, J. C., Sherry, R. M., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182829903 · Cited by 1,181
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N. J., & Mills, K. H. G. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04143.x · Cited by 975
The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
Alvarez, J. I., Dodelet-Devillers, A., Kebir, H., Ifergan, I., Fabre, P. J., Terouz, S., Sabbagh, M., Wosik, K., Bourbonnière, L., Bernard, M., et al. (2011) · Science · doi:10.1126/science.1206936 · Cited by 845
Self-citationModulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Ghoreschi, K., Jesson, M. I., Xiong, L., Lee, J. L., Ghosh, S., Alsup, J. W., Warner, J. D., Tanaka, M., Steward-Tharp, S. M., Gadina, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003668 · Cited by 651
Glial influence on the blood brain barrier
Alvarez, J. I., Katayama, T., & Prat, A. (2013) · Glia · doi:10.1002/glia.22575 · Cited by 577
Self-citationRamesh, R., Kozhaya, L., McKevitt, K., Djuretic, I. M., Carlson, T. J., Quintero, M. A., McCauley, J. L., Abreu, M. T., Unutmaz, D., & Sundrud, M. S. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20130301 · Cited by 447
Macrophages and the Recovery from Acute and Chronic Inflammation
Hamidzadeh, K., Christensen, S. M., Dalby, E., Chandrasekaran, P., & Mosser, D. M. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034348 · Cited by 449
Qiu, J., Guo, X., Chen, Z. E., He, L., Sonnenberg, G. F., Artis, D., Fu, Y., & Zhou, L. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.002 · Cited by 431
Androgen-Induced Immunosuppression
Bupp, M. G., & Jørgensen, T. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00794 · Cited by 404
Animal models of Multiple Sclerosis
Procaccini, C., Rosa, V. D., Pucino, V., Formisano, L., & Matarese, G. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.042 · Cited by 403
Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming
Roy, D. G., Chen, J., Mamane, V. H., Ma, E. H., Muhire, B. M., Sheldon, R. D., Shorstova, T., Koning, R., Johnson, R. M., Esaulova, E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.006 · Cited by 361
Disruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334
Self-citationWeber, M. S., Prod’homme, T., Patarroyo, J. C., Molnarfi, N., Karnezis, T., Lehmann‐Horn, K., Danilenko, D. M., Eastham‐Anderson, J., Slavin, A., Linington, C., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22081 · Cited by 321
Effector T Cells in Multiple SclerosisPreprint
Kaskow, B. J., & Baecher‐Allan, C. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029025 · Cited by 335
Effect of IL-17A blockade with secukinumab in autoimmune diseases
Patel, D. D., Lee, D. M., Kolbinger, F., & Antoni, C. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202371 · Cited by 313
The role of TH17 cells in multiple sclerosis: Therapeutic implications
Moser, T., Akgün, K., Proschmann, U., Sellner, J., & Ziemssen, T. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102647 · Cited by 319
Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis
Murugaiyan, G., Beynon, V., Mittal, A., Joller, N., & Weiner, H. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003952 · Cited by 289
TH17 cell heterogeneity and its role in tissue inflammation
Schnell, A., Littman, D. R., & Kuchroo, V. K. (2023) · Nature Immunology · doi:10.1038/s41590-022-01387-9 · Cited by 286
A cellular and molecular view of T helper 17 cell plasticity in autoimmunity
Stadhouders, R., Lubberts, E., & Hendriks, R. W. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.007 · Cited by 298
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 291
T cell responses in the central nervous system
Korn, T., & Kallies, A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.144 · Cited by 268
Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity
Schnell, A., Huang, L., Singer, M., Singaraju, A., Barilla, R. M., Regan, B. M. L., Bollhagen, A., Thakore, P. I., Dionne, D., Delorey, T. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.018 · Cited by 268
Th17 Cell Plasticity and Functions in Cancer Immunity
Guéry, L., & Hugues, S. (2015) · BioMed Research International · doi:10.1155/2015/314620 · Cited by 282
Interleukin-17 in chronic inflammatory neurological diseases
Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00947 · Cited by 250
Lazarevic, V., & Glimcher, L. H. (2011) · Nature Immunology · doi:10.1038/ni.2059 · Cited by 255
Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS)
Glatigny, S., & Bettelli, E. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028977 · Cited by 247
Rothhammer, V., Heink, S., Petermann, F., Srivastava, R., Claussen, M. C., Hemmer, B., & Korn, T. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110434 · Cited by 256
Ramstein, J., Broos, C. E., Simpson, L. J., Ansel, K. M., Sun, S. A., Ho, M. E., Woodruff, P. G., Bhakta, N. R., Christian, L., Nguyen, C. P., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1499oc · Cited by 260
Th17 Response and Inflammatory Autoimmune Diseases
Waite, J. C., & Skokos, D. (2011) · International Journal of Inflammation · doi:10.1155/2012/819467 · Cited by 243
Greenwood, J., Heasman, S. J., Alvarez, J. I., Prat, A., Lyck, R., & Engelhardt, B. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01140.x · Cited by 240
Self-citationT Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
Kunkl, M., Frascolla, S., Amormino, C., Volpe, E., & Tuosto, L. (2020) · Cells · doi:10.3390/cells9020482 · Cited by 248
Memory CD4+ T Cells in Immunity and Autoimmune Diseases
Raphael, I., Robinson, R. R., & Forsthuber, T. G. (2020) · Cells · doi:10.3390/cells9030531 · Cited by 241
van Langelaar, J., de Vries, R. M. V. D. V., Janssen, M., Wierenga‐Wolf, A. F., Spilt, I. M., Siepman, T. A. M., Dankers, W., Verjans, G. M. G. M., de Vries, H. E., Lubberts, E., et al. (2018) · Brain · doi:10.1093/brain/awy069 · Cited by 235
Zhang, M. A., Rego, D., Moshkova, M., Kébir, H., Chruscinski, A. J., Nguyen, H. T., Akkermann, R., Stanczyk, F. Z., Prat, A., Steinman, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118458109 · Cited by 216
Self-citationCD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
Annibali, V., Ristori, G., Angelini, D. F., Serafini, B., Mechelli, R., Cannoni, S., Romano, S., Paolillo, A., Abderrahim, H., Diamantini, A., et al. (2011) · Brain · doi:10.1093/brain/awq354 · Cited by 213
Wang, Y., Godec, J., Ben-Aissa, K., Cui, K., Zhao, K., Pucsek, A. B., Lee, Y. K., Weaver, C. T., Yagi, R., & Lazarevic, V. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.002 · Cited by 216
T helper 17 cell heterogeneity and pathogenicity in autoimmune disease
Ghoreschi, K., Laurence, A. D. J., Yang, X., Hirahara, K., & O’Shea, J. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.007 · Cited by 207
A basic overview of multiple sclerosis immunopathology
Grigoriadis, N., & Pesch, V. V. (2015) · European Journal of Neurology · doi:10.1111/ene.12798 · Cited by 220
Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
Lovett‐Racke, A. E., Yang, Y., & Racke, M. K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.05.012 · Cited by 205
Pivotal Roles of GM‐CSF in Autoimmunity and Inflammation
Shiomi, A., & Usui, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/568543 · Cited by 205
Multiple Sclerosis and T Lymphocytes: An Entangled Story
Legroux, L., & Arbour, N. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9614-0 · Cited by 206
Self-citationA role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
Kamali, A. N., Noorbakhsh, S. M., Hamedifar, H., Jadidi‐Niaragh, F., Yazdani, R., Bautista, J. M., & Azizi, G. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.11.015 · Cited by 198
Naringenin: A flavanone with anti-inflammatory and anti-infective properties
Ji, C., Wen, H., Zhou, H., Zhang, D., Lan, D., Liu, S., Li, C., Dai, X., Song, T., Wang, X., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114990 · Cited by 197
T‐cell trafficking in the central nervous system
Sallusto, F., Impellizzieri, D., Basso, C., Laroni, A., Uccelli, A., Lanzavecchia, A., & Engelhardt, B. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01140.x · Cited by 190
Boniface, K., Blumenschein, W. M., Brovont-Porth, K., McGeachy, M. J., Basham, B., Desai, B., Pierce, R. H., McClanahan, T. K., Sadekova, S., & Malefyt, R. D. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000366 · Cited by 193
van Hamburg, J. P., & Tas, S. W. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.006 · Cited by 192
Inflammation in multiple sclerosis
Haase, S., & Linker, R. A. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211007687 · Cited by 209
Chambers, E. S., Nanzer, A. M., Pfeffer, P., Richards, D. F., Timms, P. M., Martineau, A. R., Griffiths, C., Corrigan, C. J., & Hawrylowicz, C. M. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.026 · Cited by 181
Modeling the heterogeneity of multiple sclerosis in animals
Simmons, S. B., Pierson, E. R., Lee, S. Y., & Goverman, J. M. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.006 · Cited by 184
Cutting Edge: The Pathogenicity of IFN-γ–Producing Th17 Cells Is Independent of T-bet
Duhen, R., Glatigny, S., Arbelaez, C. A., Blair, T. C., Oukka, M., & Bettelli, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203172 · Cited by 176
Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells
Jain, R., Chen, Y., Kanno, Y., Joyce-Shaikh, B., Vahedi, G., Hirahara, K., Blumenschein, W. M., Sukumar, S., Haines, C. J., Sadekova, S., et al. (2016) · Immunity · doi:10.1016/j.immuni.2015.11.009 · Cited by 167
Role of ninjurin‐1 in the migration of myeloid cells to central nervous system inflammatory lesions
Ifergan, I., Kébir, H., Terouz, S., Alvarez, J. I., Lécuyer, M., Gendron, S., Bourbonnière, L., Dunay, I. R., Bouthillier, A., Moumdjian, R. A., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22519 · Cited by 167
Self-citationChang, J., Cha, H., Lee, D., Seo, K. Y., & Kweon, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012925 · Cited by 170
Advances in the immunopathogenesis of multiple sclerosis
Yadav, S. K., Mindur, J. E., Ito, K., & Dhib-Jalbut, S. S. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000205 · Cited by 173
IFN‐γ and IL‐12 synergize to convert in vivo generated Th17 into Th1/Th17 cells
Lexberg, M. H., Taubner, A., Albrecht, I., Lepenies, I., Richter, A., Kamradt, T., Radbruch, A., & Chang, H. (2010) · European Journal of Immunology · doi:10.1002/eji.201040539 · Cited by 162
Basdeo, S. A., Cluxton, D., Sulaimani, J., Moran, B., Canavan, M., Orr, C. K., Veale, D. J., Fearon, U., & Fletcher, J. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600737 · Cited by 162
Jurado, J. O., Pasquinelli, V., Alvarez, I. B., Peña, D., Rovetta, A. I., Tateosian, N. L., Romeo, H. E., Musella, R. M., Palmero, D., Chuluyán, E., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211619 · Cited by 163
Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
Хайбуллин, Т. И., Ivanova, V. V., Martynova, E. V., Черепнев, Г. В., Хабиров, Ф. А., Granatov, E. V., Rizvanov, A. A., & Khaiboullina, S. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00531 · Cited by 161
The Immunology of Multiple Sclerosis
Bar‐Or, A. (2008) · Seminars in Neurology · doi:10.1055/s-2007-1019124 · Cited by 157
Granuloma Formation in Pulmonary Sarcoidosis
Broos, C. E., van Nimwegen, M., Hoogsteden, H. C., Hendriks, R. W., Kool, M., & van den Blink, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00437 · Cited by 162
Darlington, P. J., Touil, T., Doucet, J.-S., Gaucher, D., Zeidan, J., Gauchat, D., Corsini, R., Kim, H. J., Duddy, M., Jalili, F., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23784 · Cited by 151
Self-citationKann, O., Almouhanna, F., & Chausse, B. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.10.007 · Cited by 155
Velde, C. V., McDonald, K. K., Boukhedimi, Y., McAlonis‐Downes, M., Lobsiger, C. S., Hadj, S. B., Zandona, A., Julien, J., Shah, S. B., & Cleveland, D. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022031 · Cited by 167
Immunopathogenesis of multiple sclerosis
Comabella, M., & Khoury, S. J. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.03.004 · Cited by 145
dos Passos, G. R., Sato, D. K., Becker, J., & Fujihara, K. (2016) · Mediators of Inflammation · doi:10.1155/2016/5314541 · Cited by 155
Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia
Wang, J., Xu, Y., Chen, Z., Liang, J., Lin, Z., Liang, H., Xu, Y., Wu, Q., Guo, X., Nie, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.048 · Cited by 150
Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
Tindemans, I., Joosse, M. E., & Samsom, J. N. (2020) · Cells · doi:10.3390/cells9010110 · Cited by 152
Larochelle, C., Cayrol, R., Kebir, H., Alvarez, J. I., Lécuyer, M.-A., Ifergan, I., Viel, É., Bourbonnière, L., Beauseigle, D., Terouz, S., et al. (2012) · Brain · doi:10.1093/brain/aws212 · Cited by 145
Self-citationBrown, C. C., Esterházy, D., Sarde, A., London, M., Pullabhatla, V., Osma-García, I. C., al-Bader, R., Ortiz, C., Elgueta, R., Arno, M. J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.003 · Cited by 147
Brockmann, L., Giannou, A. D., Gagliani, N., & Huber, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051033 · Cited by 152
JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation
Carr, T. M., Wheaton, J. D., Houtz, G. M., & Ciofani, M. (2017) · Nature Communications · doi:10.1038/s41467-017-00380-3 · Cited by 146
TH17 cytokines in autoimmune neuro-inflammation
Becher, B., & Segal, B. M. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.005 · Cited by 147
Gao, H., Danzi, M. C., Choi, C. S., Taherian, M., Hansen, C. D., Ellman, D. G., Madsen, P. M., Bixby, J. L., Lemmon, V., Lambertsen, K. L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.11.083 · Cited by 140
Hu, D., Notarbartolo, S., Croonenborghs, T., Patel, B., Cialic, R., Yang, T.-H., Aschenbrenner, D., Andersson, K., Gattorno, M., Pham, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01571-8 · Cited by 148
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells
Kara, E. E., McKenzie, D. R., Bastow, C. R., Gregor, C. E., Fenix, K. A., Ogunniyi, A. D., Paton, J. C., Mack, M., Pombal, D. R., Seillet, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9644 · Cited by 136
Green tea EGCG, T cells, and T cell-mediated autoimmune diseases
Wu, D., Wang, J., Pae, M., & Meydani, S. N. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.001 · Cited by 138
Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
Machhi, J., Kevadiya, B. D., Muhammad, I. K., Herskovitz, J., Olson, K. E., Mosley, R. L., & Gendelman, H. E. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00375-7 · Cited by 138
Luchtman, D. W., Ellwardt, E., Larochelle, C., & Zipp, F. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.013 · Cited by 137
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
Sweeney, C. M., Lonergan, R., Basdeo, S. A., Kinsella, K., Dungan, L. S., Higgins, S. C., Kelly, P. J., Costelloe, L., Tubridy, N. J., Mills, K. H. G., et al. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.007 · Cited by 137
Wiśniewski, J., Muehling, L. M., Eccles, J. D., Capaldo, B. J., Agrawal, R., Shirley, D.-A. T., Patrie, J. T., Workman, L. J., Schuyler, A. J., Lawrence, M. G., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.020 · Cited by 131
Ifergan, I., Kébir, H., Alvarez, J. I., Marceau, G., Bernard, M., Bourbonnière, L., Poirier, J., Duquette, P., Talbot, P. J., Arbour, N., et al. (2011) · Brain · doi:10.1093/brain/awr268 · Cited by 136
Self-citationDuhen, T. M., & Campbell, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302734 · Cited by 135
Intrinsic blood–brain barrier dysfunction contributes to multiple sclerosis pathogenesis
Nishihara, H., Perriot, S., Gastfriend, B. D., Steinfort, M., Cibien, C., Soldati, S. G., Matsuo, K., Guimbal, S., Mathias, A., Palecek, S. P., et al. (2022) · Brain · doi:10.1093/brain/awac019 · Cited by 135
Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosis
McGinley, A. M., Edwards, S. C., Raverdeau, M., & Mills, K. H. G. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.01.001 · Cited by 130
Pathogenic T cell cytokines in multiple sclerosis
Wagner, C. A., Roqué, P. J., & Goverman, J. M. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190460 · Cited by 132
Regué, D. R., Grau‐López, L., Naranjo‐Gómez, M., Ramo-Tello, C. M., Pujol‐Borrell, R., Martínez-Cáceres, E. M., & Borràs, F. E. (2012) · European Journal of Immunology · doi:10.1002/eji.201141835 · Cited by 120
Inflammasome-Derived IL-1β Regulates the Production of GM-CSF by CD4+ T Cells and γδ T Cells
Lukens, J. R., Barr, M., Chaplin, D., Chi, H., & Kanneganti, T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103308 · Cited by 117
Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis
Chuluundorj, D., Harding, S. A., Abernethy, D. A., & Flamme, A. C. L. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.15 · Cited by 119
Seeing through the dark: New insights into the immune regulatory functions of vitamin A
Brown, C. C., & Noelle, R. J. (2015) · European Journal of Immunology · doi:10.1002/eji.201344398 · Cited by 123
Nishihara, H., Soldati, S. G., Mossu, A., Rosito, M., Rudolph, H., Müller, W. A., Latorre, D., Sallusto, F., Sospedra, M., Martinꝉ, R., et al. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0165-2 · Cited by 122
Bălașa, R., Bărcuţean, L., Bălașa, A. F., Moțățăianu, A., Roman-Filip, C., & Manu, D. R. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.02.009 · Cited by 121
Dietel, B., Cicha, I., Voskens, C., Verhoeven, E. L. G., Achenbach, S. S., & Garlichs, C. D. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.014 · Cited by 109
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
Perriard, G., Mathias, A., Enz, L., Canales, M., Schluep, M., Gentner, M., Schaeren‐Wiemers, N., & Pasquier, R. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0335-3 · Cited by 114
The role of Th17 cells in auto-inflammatory neurological disorders
Tahmasebinia, F., & Pourgholaminejad, A. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.023 · Cited by 111
Chemokines and Chemokine Receptors in Multiple Sclerosis
Cheng, W., & Chen, G. (2014) · Mediators of Inflammation · doi:10.1155/2014/659206 · Cited by 108
Metadata
- Authors
- Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A.
- Affiliations
- Hôpital Notre-Dame (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2009-09
- Volume
- 66
- Issue
- 3
- Pages
- 390-402
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2127568644
- Cited by
- 551
- References
- 39
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 20 · 2023: 36 · 2022: 34 · 2021: 38 · 2020: 27 · 2019: 35 · 2018: 34 · 2017: 40 · 2016: 37 · 2015: 47 · 2014: 42 · 2013: 36 · 2012: 29
- FWCI
- 22.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- multiple sclerosis, experimental autoimmune encephalomyelitis, Th17 cells, interferon-gamma, IL-17, IL-23, blood-brain barrier, T-bet, memory T cells, relapsing multiple sclerosis
- MeSH terms
- Adult, Animals, Blood-Brain Barrier, Brain, Cell Migration Inhibition, Central Nervous System, Encephalomyelitis, Autoimmune, Experimental, Female, Humans, Interferon-gamma, Mice, Inbred C57BL, Middle Aged, Multiple Sclerosis, T-Lymphocytes, Th1 Cells, Th2 Cells, Interleukin-17, Multiple Sclerosis, Relapsing-Remitting, Mice, Interleukin-23, Cell Migration Assays, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review